2,2,2-TRIFLUORO-1-(3-FLUOROPHENYL)ETHANOL, 95.0%, 5g

1-Bromo-7-methoxynaphthalene, 95+%, 10g

GC capillary column ROTI®Cap-1, 25 m, 0.20 mm, 0.10 µm, 1 Piece(s)

3,3,3-Trifluoro-2-methylpropanoic acid, 95.0%, 1g

ethyl 2-anilino-4-oxo-4,5-dihydrothiophene-3-carboxylate, 95+%, 10g

4-(2-Amino-2-carboxyethyl)benzoic acid, 95.0%, 250mg

5-Bromo-1-methyl-1H-pyrazole, 95.0%, 100g

4-(Pyren-1-yl)butanoic acid, 95.0%, 5g

(R)-3-Methoxy-piperidine, 95.0%, 5g

4-Ethynyl-N,N-dimethylaniline>98.0%(GC)(T)5g

2-Bromo-5-(difluoromethyl)-1,3,4-thiadiazole, 97%, 1g

6-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 500mg

3-Formyl-4-hydroxybenzoic acid, 95.0%, 10g